Olivera J. Finn

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Martin A. Cheever, James P. Allison, Andrea Stern Ferris et al. · Clinical Cancer Research · 2009 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +16

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Jan Schmielau, Olivera J. Finn · PubMed · 2001 · 872 citations

Life Sciences, Immunology, Oncology +11

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Donna L. Barnd, Michael S. Lan, Richard S. Metzgar et al. · Proceedings of the National Academy of Sciences · 1989 · 454 citations · Full text

Life Sciences, Immunology, Oncology +17

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

Keith R. Jerome, Donna L. Barnd, Katharine M. Bendt et al. · PubMed · 1991 · 353 citations

Life Sciences, Immunology, Oncology +17

Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

Y Kotera, J D Fontenot, Gabriele Pecher et al. · PubMed · 1994 · 314 citations

Life Sciences, Immunology, Oncology +15